Physician

Adam Ben Bodian, MD

According to 2025 Medicare claims, Adam Bodian, MD (NPI: 1518033687) practices dermatology in the Nassau County-Suffolk County, NY market, with the plurality of this provider's patient population coming from Nassau, NY. This provider's primary affiliated billing organization is BODIAN DERMATOLOGY GROUP, P.C (NPI: 1659412104; TIN: 112234296) and primary practice location at 11021-2417.

Bodian's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,066 traditional Medicare patients, billed 5,071 HCPCS/CPT codes, and received $344,969 in Medicare payments. The top billing code was 11102 (Biopsy of related skin growth, first growth). Part D data shows 630 prescription claims across 311 beneficiaries totaling $104,768 in drug costs, led by Clobetasol Propionate (Clobetasol Propionate). Open Payments data shows 72 records totaling $1,486. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $124,171 to $104,768. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$172K$345K2015 Medicare payment: $285,650 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $276,272 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $257,596 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $256,306 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $296,446 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $272,199 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $297,822 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $301,449 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $297,257 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $344,969 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20158934,994$285,650
20168925,319$276,272
20179104,972$257,596
20188634,418$256,306
20199205,592$296,446
20208524,886$272,199
20219384,756$297,822
20229274,629$301,449
20239754,573$297,257
20241,0665,071$344,969

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$199K$397K2015 Drug cost: $124,171 (USD; Tot_Drug_Cst)2016 Drug cost: $130,134 (USD; Tot_Drug_Cst)2017 Drug cost: $163,653 (USD; Tot_Drug_Cst)2018 Drug cost: $344,215 (USD; Tot_Drug_Cst)2019 Drug cost: $357,904 (USD; Tot_Drug_Cst)2020 Drug cost: $397,396 (USD; Tot_Drug_Cst)2021 Drug cost: $344,620 (USD; Tot_Drug_Cst)2022 Drug cost: $280,028 (USD; Tot_Drug_Cst)2023 Drug cost: $226,032 (USD; Tot_Drug_Cst)2024 Drug cost: $104,768 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015158365$124,171
2016185459$130,134
2017214517$163,653
2018221502$344,215
2019221539$357,904
2020252690$397,396
2021256586$344,620
2022273592$280,028
2023258562$226,032
2024311630$104,768

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
11102Biopsy of related skin growth, first growth347452$86
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more7531,281$79
17000Destruction of precancer skin growth, 1 growth292405$56
99212Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more322458$51
17003Destruction of precancer skin growth, 2-14 growths2141,047$6

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Clobetasol PropionateClobetasol Propionate471,322$1,977
FluorouracilFluorouracil351,051$1,856
Triamcinolone AcetonideTriamcinolone Acetonide1083,227$1,450
KetoconazoleKetoconazole511,455$1,033
Doxycycline HyclateDoxycycline Hyclate46792$804

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.72$1,486ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Adam Ben Bodian, MD?

Tedicare shows public-source Medicare data for Adam Ben Bodian, MD (NPI 1518033687), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adam Ben Bodian, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Adam Ben Bodian, MD?

Adam Ben Bodian, MD is linked to BODIAN DERMATOLOGY GROUP, P.C (billing NPI 1659412104) in the available physician profile data.

Does Adam Ben Bodian, MD have Open Payments data?

Adam Ben Bodian, MD has 72 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.